VanEck Biotech ETF is a ETF series of VanEck ETF Trust (series S000034406). Net assets $371.6M as of 2026-03-31. Index fund.
Showing 15 of 25 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Gilead Sciences Inc | — | $54.4M | 1463.08% |
| Amgen Inc | — | $54.0M | 1454.22% |
| Vertex Pharmaceuticals Inc | — | $29.9M | 805.77% |
| Regeneron Pharmaceuticals Inc | — | $27.9M | 751.28% |
| Argenx SE | — | $19.6M | 527.69% |
| Insmed Inc | — | $17.1M | 458.93% |
| IQVIA Holdings Inc | — | $16.0M | 429.80% |
| Alnylam Pharmaceuticals Inc | — | $15.3M | 410.66% |
| Natera Inc | — | $14.8M | 397.89% |
| United Therapeutics Corp | — | $14.1M | 380.69% |
| Biogen Inc | — | $13.8M | 372.21% |
| BeOne Medicines Ltd | — | $12.1M | 324.64% |
| Moderna Inc | — | $11.5M | 310.21% |
| Revolution Medicines Inc | — | $10.6M | 286.22% |
| Illumina Inc | — | $9.3M | 249.22% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $371.6M |
| 2025-12-31 | $375.8M |
| 2025-09-30 | $347.3M |
| 2025-06-30 | $330.6M |
| 2025-03-31 | $365.9M |
| 2024-12-31 | $396.5M |
| 2024-09-30 | $452.0M |
| 2024-06-30 | $433.6M |